ENCell Co (XKRX:456070) Change In Payables And Accrued Expense : ₩0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Change In Payables And Accrued Expense?

ENCell Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ₩0 Mil. It means ENCell Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

ENCell Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ₩0 Mil. It means ENCell Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

ENCell Co Change In Payables And Accrued Expense Historical Data

The historical data trend for ENCell Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Change In Payables And Accrued Expense Chart

ENCell Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

ENCell Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial					-	-	-	-	-

ENCell Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

ENCell Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of ENCell Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR

Website

http://www.encellinc.com

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines